FDA gives Rare Paediatric Disease designation to Satellite Bio for urea cycle disorders
The mortality rates of UCDs exceeds 25%, with no curative treatment available for newborns
The mortality rates of UCDs exceeds 25%, with no curative treatment available for newborns
COPD affects nearly 400 million people globally and is the third leading cause of death worldwide
The companies aim to advance treatments for narcolepsy and other sleep-wake disorders
The mortality rates of UCDs exceeds 25%, with no curative treatment available for newborns
The data underlines the consequences of disrupted sleep for patients and caregivers
Nigel Breakwell was formerly Joint CEO of Edelman London and MD of WCG
May 6, 2026 | Appointments
Irion was previously CSO at BlueRock Therapeutics, a Bayer subsidiary
Read MoreMay 5, 2026 | Appointments
Owen was most recently Senior Vice President for Clinical Operations at Caidya
Read MoreMay 1, 2026 | Appointments
Malkomes was most recently CFO at CureVac
Read MoreApr 29, 2026 | Appointments
Kramer most recently served as VP and Head of Medical Neuroscience at Bristol Myers Squibb
Read More
Mar 30, 2026 | Intelligence
As new comms excellence opportunities abound, staying connected through core messaging remains critical
Read MoreMar 5, 2026 | Intelligence
Despite the GenAI fervour, there is an acute need to prepare organisations to understand which specific tools they need and how to use them
Read MoreFeb 25, 2026 | Intelligence
AI has graduated from being a procurer of efficiencies to seemingly an enabler of unimagined possibilities
Read MoreFeb 18, 2026 | Intelligence
Why soft skills are more important than ever in life sciences
Read MoreFeb 17, 2026 | Intelligence
RFID has emerged as a key technology for its rapid, accurate data capture, and track and trace capabilities for manufacturing and supply chain operations
Read MoreFeb 16, 2026 | Intelligence
COVID-19 showed how quickly a health emergency becomes a fiscal event: disrupting supply chains, reshaping capital allocation and exposing governance weaknesses
Read More

May 6, 2026 | Havas Lynx|Havas Lynx
Starting out in 1986 as a team of two in Manchester’s Northern Quarter, Havas Lynx has much to celebrate, having grown to become an international …

May 6, 2026 | Cuttsy + Cuttsy|New Team Members
Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.

May 6, 2026 | Uniphar|Durbin PLC, Expanded access, Global sourcing, Medicine supply, NHS, Uniphar
Against the backdrop of widespread medicine shortages, Durbin PLC’s rebrand to Uniphar and integration into Uniphar | Global Sourcing represents a strategic move to address …

May 5, 2026 | Inizio|
Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence
![]()
May 5, 2026 | Mednet|Innovation, Making Health Whole, Medical Communications
In healthcare, disengagement rarely announces itself. It doesn’t always appear as refusal or a clear decision to stop treatment. More often, it shows up quietly, …
April 30, 2026 | Uniphar|
Expanded access programs (EAPs) play a multifaceted role in the drug development life cycle, serving as a critical bridge between clinical trials and commercial availability.
April 27, 2026 | Cuttsy + Cuttsy|Reddit, Social Listening, symptoms, weight loss
Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.
April 21, 2026 | Cuttsy + Cuttsy|Engagement, Site Teams, Site-centric, clinical research, clinical trials, recruitment, retention
Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.
August 19, 2025 | Inizio | healthcare
